A big dream. An even bigger frontier where anything is possible.
To learn more about Bellerophon, please go to www.bellerophon.com.
- Bryan NS, Bian K, Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci. 2009;14:1-18.
- Ng CKF, Chan MHM, Tai MHL, Lam CWK. Hepatorenal syndrome. Clin Biochem Rev. 2007;28(1):11-17.
- Landa N, Miller L, Feinberg MS, et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117(11):1388-1396.
INOMAX and INOtherapy are registered trademarks of INO Therapeutics LLC.
Bioabsorbable Cardiac Matrix—Licensed from BioLineRx (BL-1040).